Jung Sun Yum

Title: Jung Sun Yum: Innovator in Vaccine Development

Introduction

Jung Sun Yum is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of vaccine development, holding a total of 3 patents. His work focuses on enhancing the efficacy of vaccines through innovative adjuvant formulations.

Latest Patents

One of his latest patents is titled "Vaccine adjuvant comprising lipopeptide-inserted liposome as effective ingredient and use thereof." This invention relates to a recombinant herpes zoster vaccine that utilizes liposomes and lipopeptides. The vaccine composition, prepared using Lipo-Pam, a composite adjuvant, is designed to induce both cell-mediated and humoral immune responses, making it commercially valuable. Another notable patent is for an "HBV vaccine and a process of preparing the same." This invention involves a vaccine comprising the entire hepatitis B surface antigen, which forms virus-like particles. The multi-antigen vaccine also includes an HBV core antigen, providing various epitopes and excellent immunogenicity.

Career Highlights

Jung Sun Yum has worked with notable organizations such as Dobeel Corporation and Cha Vaccine Research Institute Co., Ltd. His experience in these companies has contributed to his expertise in vaccine research and development.

Collaborations

He has collaborated with several professionals in the field, including Byung Cheol Ahn and Hyun Jin Jo, who have supported his innovative research endeavors.

Conclusion

Jung Sun Yum's contributions to vaccine technology highlight his role as a key innovator in the field. His patents reflect a commitment to advancing public health through effective vaccine solutions.